نتائج البحث - "Julia Karbach"

المساهمون: Clinicum, Medicum, Department of Oncology, Institute for Molecular Medicine Finland, Johan Edvard Lundin / Principal Investigator, Department of Pathology, Gastrointestinal tumorigenesis

المصدر: Journal for Immunotherapy of Cancer

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5ca2cc3e2ac5b0472e34724c7f0155Test
http://europepmc.org/articles/PMC4791966Test

6

Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients

المؤلفون: Dmitry V. Kuprash, Svetlana V. Khlgatian, Sergei A. Nedospasov, Elke Jäger, Julia Karbach, Alexander Knuth, Nai Wen Chi, Inna N. Lavrik, Kirill N. Kashkin, Yuriy V. Shebzukhov, Ekaterina P. Koroleva, P. V. Belousov

المصدر: Cancer Immunology, Immunotherapy. 57:871-881

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bad64f1f3a6bd600bf7af0d1174a71Test
https://doi.org/10.1007/s00262-007-0423-zTest

7

Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy

المؤلفون: Yuriy V. Shebzukhov, Andrey Meshcheryakov, Ekaterina P. Koroleva, Sergei A. Nedospasov, Maria A. Lagarkova, Julia Karbach, Elke Jäger, Mikhail Lichinitser, Svetlana V. Khlgatian, Dmitry V. Kuprash

المصدر: Immunology Letters. 100:88-93

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2afe0f572935436fb92307c2a6085f6Test
https://doi.org/10.1016/j.imlet.2005.06.011Test

8

Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8(+) T-cell response, prominent infiltration of CD8(+) lymphocytes and Th1 type polarization

المساهمون: Institute for Molecular Medicine Finland, Haartman Institute (-2014), Department of Pathology, Research Programs Unit, Genome-Scale Biology (GSB) Research Program, Clinicum, Gastrointestinal tumorigenesis

المصدر: Oncoimmunology

مصطلحات موضوعية: Oncolytic adenovirus, medicine.medical_treatment, antitumor immunity, Immunology, education, 3122 Cancers, IRF1, interferon regulatory factor 1, Active immunotherapy, Biology, APC, antigen presenting cell, THERAPY, PET, positron emission tomography, ELISPOT, enzyme-linked immunospot assay, 03 medical and health sciences, 0302 clinical medicine, Immune system, CXCL10, (C-X-C motif) ligand 10, CTCAE, common terminology criteria for adverse events, medicine, Immunology and Allergy, Cytotoxic T cell, Adenovirus, TOLERANCE, 030304 developmental biology, VP, viral particle, 0303 health sciences, Tumor microenvironment, Tumor-infiltrating lymphocytes, Brief Report, IFNg, interferon gamma, Immunosuppression, GM-CSF, CX3CL1, (C-X3-C motif) ligand 1, CANCER, Tumor antigen, CCL2, (C-Cmotif) ligand 2, 3. Good health, CXCL9, (C-X-C motif) ligand 9, GM-CSF, granulocyte macrophage colony stimulating factor, Oncology, TILs, tumor infiltrating lymphocytes, Th1 polarization, tumor infiltrating lymphocytes, 030220 oncology & carcinogenesis, cytotoxic immunotherapy, RANTES, regulated on activation, normal T cell expressed and secreted